Actavis, Inc. News Headlines

Get ACT Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
AstraZeneca Unveils $600M Deal To Buy Actavis' Lung Drugs
2/5/2015 3:05:00 PM - Seeking Alpha

Millennium Management exits position in Procter & Gamble
2/5/2015 2:05:00 PM - Market Realist

Pfizer To Buy Hospira For $15.23 Bln
2/5/2015 12:45:00 PM - RTT News

European Markets Finished Mixed On Renewed Greek Concerns
2/5/2015 12:03:00 PM - RTT News

Predictable Fast Growing Healthcare Dividend Growth And Growth Stocks For Your Retirement Portfolios: Part 5
2/5/2015 11:51:00 AM - Seeking Alpha

Millennium Management exits stake in Forest Laboratories
2/5/2015 11:06:00 AM - Market Realist

Today's Market: Mergers And Acquisitions Driving Markets And These Stocks Higher
2/5/2015 10:33:00 AM - Seeking Alpha

AstraZeneca Q4 Adj. Profit Misses View, To Buy Actavis'' Respiratory Drug Unit
2/5/2015 10:20:00 AM - RTT News

DPLO To Dispense Breast Cancer Drug, New Use For Old Drugs Sought, CANF On Watch
2/5/2015 8:12:00 AM - RTT News

AstraZeneca to Buy Actavis's Respiratory Drug Business in U.S., Canada -- 2nd Update
2/5/2015 6:39:00 AM - Dow Jones Business News

AstraZeneca to Buy Actavis''s Respiratory Drug Business in U.S., Canada -- 2nd Update
2/5/2015 6:39:00 AM - Dow Jones Business News

European Shares Fall On Greek Uncertainty
2/5/2015 6:17:00 AM - RTT News

AstraZeneca To Buy Actavis'' U.S. Respiratory Portfolio - Quick Facts
2/5/2015 2:24:00 AM - RTT News

Allergan Profit Surges On Higher Sales Ahead Of Actavis Takeover
2/4/2015 5:59:00 PM - Dow Jones Business News

Actavis Says FDA Accepts SNDA To Expand TEFLARO Labeling - Quick Facts
2/4/2015 8:11:00 AM - RTT News

3 Reasons To Buy Actavis Plc
2/3/2015 9:57:00 AM - Seeking Alpha

Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha

Valeant to Buy Prostate-Cancer Drug From Dendreon
1/29/2015 11:15:00 PM - Dow Jones Business News

Valeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
1/29/2015 10:54:00 PM - Dow Jones Business News

$CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon
1/29/2015 4:13:00 PM - Seeking Alpha

Elite Pharmaceuticals Is Well Positioned To Address $7B Abuse Deterrent Opioid Market
1/29/2015 8:06:00 AM - Seeking Alpha

Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog
1/28/2015 6:30:00 AM - Investopedia

Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales? - Analyst Blog
1/28/2015 5:50:00 AM - Investopedia

Pfizer Hit by Stronger Dollar, Patent Losses -- 2nd Update
1/27/2015 4:21:00 PM - Dow Jones Business News

Will Biogen (BIIB) Surpass Q4 Earnings Expectations? - Analyst Blog
1/27/2015 12:00:00 PM - Investopedia